Загрузка...
New Drugs for Treating Dyslipidemia: Beyond Statins
Statins have been shown to be very effective and safe in numerous randomized clinical trials, and became the implacable first-line treatment against atherogenic dyslipidemia. However, even with optimal statin treatment, 60% to 80% of residual cardiovascular risk still exists. The patients with famil...
Сохранить в:
| Опубликовано в: : | Diabetes Metab J |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Diabetes Association
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4411552/ https://ncbi.nlm.nih.gov/pubmed/25922802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2015.39.2.87 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|